Popliteal Sciatic Nerve Block: Intraneural or Extraneural?

NCT01987128 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 88

Last updated 2015-02-27

No results posted yet for this study

Summary

Aim of this study is to demonstrate the advantages of intraneural injection over extraneural injection in terms of onset and duration on peripheral block. In addition we will evaluate the frequency of possible adverse effects.

Conditions

  • Hallux Valgus

Interventions

PROCEDURE

Intraneural injection

BBraun Ropivacaine 1% 12ml injection divided in each sciatic components under echographic guidance with a PAJUNK SonoPlex 22G needle.

PROCEDURE

Extraneural injection

BBraun Ropivacaine 1% 12ml extraneural injection around sciatic nerve under echographic guidance with a PAJUNK SonoPlex 22G needle.

DRUG

Ropivacaine

DEVICE

PAJUNK SonoPlex 22G needle.

Sponsors & Collaborators

  • ASST Gaetano Pini-CTO

    lead OTHER

Principal Investigators

  • Gianluca Cappelleri, MD · ASST Gaetano Pini-CTO

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2015-02-28
Completion
2015-02-28

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01987128 on ClinicalTrials.gov